Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Simple Tool Provides Reliable Method for Identifying Pathogens

By LabMedica International staff writers
Posted on 15 Dec 2023

The overuse of antibiotics globally has led to an increase in antibiotic-resistant bacteria, making the treatment of bacterial diseases increasingly challenging. More...

Antibiotics are a crucial tool in combating these infections, and reducing their usage is essential. To aid in this effort, researchers have devised a new method for identifying bacteria that is simpler, less expensive, and more accurate than previous techniques. This advancement could play a significant role in reducing antibiotic use.

The new method developed by an international research group led by the Norwegian University of Science and Technology (NTNU, Trondheim, Norway) is faster because it eliminates the need for 'gene amplification'. This traditional step, which involves creating multiple copies of genetic material for easier analysis, is no longer necessary. The innovative method focuses on detecting short DNA sequences of bacteria. It achieves this by observing the binding of these sequences to various DNA variants are grafted onto colloids – particles suspended in a liquid.

This approach allows for rapid bacterial identification by analyzing how different bacteria bind to these colloids, causing the, to clump together. The advantage here is the reduced need for analyzing large volumes of genetic material and the ability to bypass the gene copying process. This results in time and cost savings. While this method is still in the early stages of development, it holds significant potential, especially in a context where antibiotic resistance is a growing concern. More work is needed to bring this method into mainstream usage

“We have developed a simple tool that can identify all of the genetic material in bacteria,” said Professor Erika Eiser at NTNU’s Department of Physics. “This allows us to find out more quickly what kind of bacteria a sick person or animal is affected by, or what kind of bacteria are found in food or the environment. We can then also decide whether it is necessary to use antibiotics against the bacterium, and if so what kind, so we don’t have to use as much medication.”

Related Links:
NTNU 


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.